sodium selenite has been researched along with Parkinson Disease, Secondary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SD; Ding, JQ; Li, W; Tian, LP; Wang, Y; Xu, L; Zhang, S | 1 |
1 other study(ies) available for sodium selenite and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Selenite benefits embryonic stem cells therapy in Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents; Cell Culture Techniques; Cell Differentiation; Cell Survival; Cells, Cultured; Corpus Striatum; Culture Media, Serum-Free; Cyclooxygenase 2; Dopaminergic Neurons; Embryonic Stem Cells; Graft Survival; Inflammation; Lipopolysaccharides; Male; Microglia; Nitric Oxide Synthase Type II; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Sodium Selenite; Transplantation Tolerance; Tyrosine 3-Monooxygenase | 2012 |